Likewise, as an endogenous compound, APN also has the ability to activate SIRT1 and its downstream molecules [28], but in ischemic stroke it is unreported whether exogenous APN treatment has protective effects against oxidative stress damage via activation of SIRT1 and its downstream molecules. The gene discussed is SIRT1; the disease is ischemic stroke.